Your session is about to expire
← Back to Search
Ultrasound Contrast Agent
Normal controls for Myocardial Ischemia
Phase < 1
Waitlist Available
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
NORMAL CONTROL GROUP
Normal control individuals
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
The overall aim of this study is to determine whether non-invasive imaging with myocardial contrast echocardiography using can provide information on the presence and spatial extent of recent myocardial ischemia by non-invasive echocardiographic imaging.
Eligible Conditions
- Myocardial Ischemia
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Detection of Ischemia
Dose optimization
Trial Design
2Treatment groups
Experimental Treatment
Group I: Patients with ACSExperimental Treatment1 Intervention
Subjects with ACS who have undergone primary percutaneous intervention in whom MCE with phosphatidylserine-containing microbubbles will be performed to determine whether the risk area can be detected and spatially defined.
Group II: Normal controlsExperimental Treatment1 Intervention
Normal controls who will undergo dose-ranging studies to determine the optimal dose of phosphatidylserine-containing microbubbles that does not produce delayed myocardial opacification on myocardial contrast echocardiography (MCE).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Perflubutane
FDA approved
Find a Location
Who is running the clinical trial?
Oregon Health and Science UniversityLead Sponsor
966 Previous Clinical Trials
6,845,711 Total Patients Enrolled
1 Trials studying Myocardial Ischemia
5 Patients Enrolled for Myocardial Ischemia
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger